These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 15246210
1. Phenprocoumon-induced liver disease ranges from mild acute hepatitis to (sub-) acute liver failure. Schimanski CC, Burg J, Möhler M, Höhler T, Kanzler S, Otto G, Galle PR, Lohse AW. J Hepatol; 2004 Jul; 41(1):67-74. PubMed ID: 15246210 [Abstract] [Full Text] [Related]
2. [Acute liver failure caused by phenprocoumon -- three case reports]. Bulang T, Schönlebe J, Haroske G, Porst H. Z Gastroenterol; 2004 Sep; 42(9):1055-8. PubMed ID: 15455285 [Abstract] [Full Text] [Related]
8. [Liver injury caused by coumarin anticoagulants: experience of the IKS (Intercanton Monitoring Station) and the SANZ (Swiss Center for Drug Monitoring)]. Ciorciaro C, Hartmann K, Stoller R, Kuhn M. Schweiz Med Wochenschr; 1996 Dec 07; 126(49):2109-13. PubMed ID: 8999497 [Abstract] [Full Text] [Related]
9. Liver damage induced by coumarin anticoagulants. Ehrenforth S, Schenk JF, Scharrer I. Semin Thromb Hemost; 1999 Dec 07; 25(1):79-83. PubMed ID: 10327225 [Abstract] [Full Text] [Related]
14. [Phenprocoumon-induced cholestatic hepatitis]. Woolley S, Burger HR, Zellweger U. Dtsch Med Wochenschr; 1995 Nov 03; 120(44):1507-10. PubMed ID: 7588020 [Abstract] [Full Text] [Related]
15. Phenprocoumon-induced hepatitis in a patient with a combined hereditary hemostatic disorder. Bux-Gewehr I, Zotz RB, Scharf RE. Thromb Haemost; 2000 May 03; 83(5):799-800. PubMed ID: 10823289 [No Abstract] [Full Text] [Related]
16. [Off label use in long-term anticoagulation after liver transplantation due to phenprocoumon-induced hepatic failure]. Bertsche T, Fritz R, Sauer P, Encke J, Haefeli WE, Walter-Sack I. Med Monatsschr Pharm; 2006 Jul 03; 29(7):257-62. PubMed ID: 16866079 [Abstract] [Full Text] [Related]
17. Coumarin-associated hepatitis. Report of two cases. Slagboom G, Loeliger EA. Arch Intern Med; 1980 Aug 03; 140(8):1028-9. PubMed ID: 7396606 [Abstract] [Full Text] [Related]
18. Evidence for immunological (allergic) mechanisms in a subgroup of patients with phenprocoumon-induced liver disease. Klein R. Eur J Clin Pharmacol; 2009 Dec 03; 65(12):1195-201. PubMed ID: 19641912 [Abstract] [Full Text] [Related]
19. Acenocoumarol is not a safe alternative for anticoagulation in phenprocoumon-induced hepatic failure. Report of two cases. Neef M, Kerekes Z, Fischer HP, Sauerbruch T, Spengler U. Digestion; 2003 Dec 03; 67(1-2):100-4. PubMed ID: 12743448 [Abstract] [Full Text] [Related]
20. Adverse reactions to anticoagulants and to antiplatelet drugs recorded by the German spontaneous reporting system. Tiaden JD, Wenzel E, Berthold HK, Müller-Oerlinghausen B. Semin Thromb Hemost; 2005 Dec 03; 31(4):371-80. PubMed ID: 16149013 [Abstract] [Full Text] [Related] Page: [Next] [New Search]